NR 546 Final PRACTICE EXAM
Psychopharmacology
1. MAOIs (monoamine oxidase inhibitors) affect A. Serotonin, Dopamine,
which neurotransmitters? Norepinephrine
A. Serotonin, Dopamine, Norepinephrine
B. Serotonin, GABA, Glutamate
C. Acetylcholine, Dopamine, Norepinephrine
D. Dopamine, GABA, Acetylcholine
2. Which of the following is considered first A. SSRI
line treat- ment for depression?
A. SSRI
B. FGA
C. SNRI
D. MAOI
3. When treating a patient for major depression disorder C.
Escitalopram
which medication would the PMHNP consider first?
A. Depakote
B. Selegiline
C. Escitalopram
D. Isocarboxazid
4. Which of the following medication should be D. Carbemaz
consid- ered for a patient diagnosed with epine
major depressive disorder who reports
"always forgetting to take my pills"?
A. Mirtazapine
B. Fluvoxamine
C. Fluoxetine
1/
47
, NR 546 Final PRACTICE EXAM
Psychopharmacology
C. Fluoxetine
2/
47
, NR 546 Final PRACTICE EXAM
Psychopharmacology
5. Which of the following medication has a B. Lamotrigine
black box warning of a life-threatening
skin rash?
A. Lithium
B. Lamotrigine
C. Lurasidone
D. Lorazepam
D. Escitalopram
6. Which medication is considered the best
tolerated SSRI?
A. Venlafaxine
B. Bupropion
C. Setraline
D. Escitalopram
7. During a 4 week follow up appointment, Rashida, who A. Increase
Setraline dose
is prescribed Sertraline 25mg qAM reports slight
im- provement in depression symptoms and
tolerating medication well. Which of the
following should the PMHNP do?
A. Increase Setraline dose
B. Switch to an SNRI
C. Switch to a different SSRI
D. Add Trazodone qHS for sleep.
8. Which medication should be avoided for the reported
66 year patient diagnosed with major fall 3
depressive disorder and anxiety with a months
3/
47
, NR 546 Final PRACTICE EXAM
Psychopharmacology
ago? C. Paroxetine
A. Citalopram
4/
47
Psychopharmacology
1. MAOIs (monoamine oxidase inhibitors) affect A. Serotonin, Dopamine,
which neurotransmitters? Norepinephrine
A. Serotonin, Dopamine, Norepinephrine
B. Serotonin, GABA, Glutamate
C. Acetylcholine, Dopamine, Norepinephrine
D. Dopamine, GABA, Acetylcholine
2. Which of the following is considered first A. SSRI
line treat- ment for depression?
A. SSRI
B. FGA
C. SNRI
D. MAOI
3. When treating a patient for major depression disorder C.
Escitalopram
which medication would the PMHNP consider first?
A. Depakote
B. Selegiline
C. Escitalopram
D. Isocarboxazid
4. Which of the following medication should be D. Carbemaz
consid- ered for a patient diagnosed with epine
major depressive disorder who reports
"always forgetting to take my pills"?
A. Mirtazapine
B. Fluvoxamine
C. Fluoxetine
1/
47
, NR 546 Final PRACTICE EXAM
Psychopharmacology
C. Fluoxetine
2/
47
, NR 546 Final PRACTICE EXAM
Psychopharmacology
5. Which of the following medication has a B. Lamotrigine
black box warning of a life-threatening
skin rash?
A. Lithium
B. Lamotrigine
C. Lurasidone
D. Lorazepam
D. Escitalopram
6. Which medication is considered the best
tolerated SSRI?
A. Venlafaxine
B. Bupropion
C. Setraline
D. Escitalopram
7. During a 4 week follow up appointment, Rashida, who A. Increase
Setraline dose
is prescribed Sertraline 25mg qAM reports slight
im- provement in depression symptoms and
tolerating medication well. Which of the
following should the PMHNP do?
A. Increase Setraline dose
B. Switch to an SNRI
C. Switch to a different SSRI
D. Add Trazodone qHS for sleep.
8. Which medication should be avoided for the reported
66 year patient diagnosed with major fall 3
depressive disorder and anxiety with a months
3/
47
, NR 546 Final PRACTICE EXAM
Psychopharmacology
ago? C. Paroxetine
A. Citalopram
4/
47
